Research Site

Porto Alegre/RS 90035-903

0 studies enrolling now · 1 studies all time

What they study most

Healthy

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants — Completed